TruAlt Bioenergy IPO GMP Today
TruAlt Bioenergy IPO opens on 25 September 2025. TruAlt Bioenergy IPO GMP is Rs 90.00 today. Listing price estimate is Rs 586.00 (issue price Rs 496.00). Listing gain estimate: 18.15%.
Issue Price
Rs 496.00
GMP Today
Rs 90.00
GMP %
+18.15%
Listing Price
Rs 586.00
Listing Gain / Lot
Rs 2,700.00
Listing Date
3 Oct 2025
TruAlt Bioenergy IPO GMP Day Wise
GMP for TruAlt Bioenergy IPO started at Rs 0 on 20 September 2025 and stood at Rs 75 on 30 September 2025. The sharpest single-day jump was from Rs 0 on 21 Sept 2025 to Rs 54 on 22 Sept 2025. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Estimated Profit |
|---|---|---|---|---|
| 30 Sept 2025Today | Rs 496.00 | Rs 75.00 | Rs 571.00 (+15.12%) | Rs 2,250.00 |
| 29 Sept 2025 | Rs 496.00 | Rs 107.00 | Rs 603.00 (+21.57%) | Rs 3,210.00 |
| 28 Sept 2025 | Rs 496.00 | Rs 109.00 | Rs 605.00 (+21.98%) | Rs 3,270.00 |
| 27 Sept 2025 | Rs 496.00 | Rs 98.00 | Rs 594.00 (+19.76%) | Rs 2,940.00 |
| 26 Sept 2025 | Rs 496.00 | Rs 95.00 | Rs 591.00 (+19.15%) | Rs 2,850.00 |
| 25 Sept 2025 | Rs 496.00 | Rs 80.00 | Rs 576.00 (+16.13%) | Rs 2,400.00 |
| 24 Sept 2025 | Rs 496.00 | Rs 80.00 | Rs 576.00 (+16.13%) | Rs 2,400.00 |
| 23 Sept 2025 | Rs 496.00 | Rs 60.00 | Rs 556.00 (+12.10%) | Rs 1,800.00 |
| 22 Sept 2025 | Rs 496.00 | Rs 54.00 | Rs 550.00 (+10.89%) | Rs 1,620.00 |
| 21 Sept 2025 | Rs 496.00 | Rs 0.00 | Rs 496.00 (+0.00%) | Rs 0.00 |
| 20 Sept 2025 | Rs 496.00 | Rs 0.00 | Rs 496.00 (+0.00%) | Rs 0.00 |
TruAlt Bioenergy IPO Listing Price
Based on today's GMP, TruAlt Bioenergy IPO listing price estimate is Rs 586.00 per share (issue price Rs 496.00 + GMP Rs 90.00).
Actual listing price will be known on 3 October 2025 when the stock lists on NSE/BSE.
TruAlt Bioenergy IPO Listing Gain
Lot size: 30 shares
GMP today: Rs 90.00
Estimated listing gain per lot: Rs 90.00 × 30 = Rs 2,700.00
GMP at roughly 18.1% suggests solid informal demand. The grey market expects the stock to list noticeably above the issue price.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
TruAlt Bioenergy IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for TruAlt Bioenergy IPO is 75.02x. Compare this with the GMP trend to see if demand aligns. The GMP move around 22 Sept 2025 may reflect how the market reacted once the subscription window activity picked up after 25 Sept 2025.
See live figures on the TruAlt Bioenergy IPO Subscription Status page.
TruAlt Bioenergy IPO Details
| Field | Value |
|---|---|
| Price Band | ₹472.0 - ₹496.0 |
| Issue Size | ₹839.28 Cr |
| Lot Size | 30 shares |
| IPO Type | Mainboard |
| Open Date | 25 Sept 2025 |
| Close Date | 29 Sept 2025 |
| Listing Date | 3 Oct 2025 |
| Subscription | 75.02x |
TruAlt Bioenergy IPO full details (financials, peers, review).
About TruAlt Bioenergy IPO
No company information available
TruAlt Bioenergy IPO GMP FAQs
What is TruAlt Bioenergy IPO IPO GMP today?
TruAlt Bioenergy IPO IPO GMP is ₹90 as of 20 July 2026, 9:32 AM IST. At issue price ₹496, that is +18.15% expected listing gain in the grey market.
What is TruAlt Bioenergy IPO IPO grey market premium (GMP)?
The grey market premium (GMP) for TruAlt Bioenergy IPO IPO is ₹90 today. GMP is the unofficial premium traders pay above the issue price of ₹496 before listing on NSE/BSE.
What is TruAlt Bioenergy IPO IPO expected returns?
TruAlt Bioenergy IPO IPO expected returns based on today's GMP are +18.15% over the issue price of ₹496. Estimated listing price is ₹586 per share. Actual listing gain on 3 October 2025 may differ.
What is the estimated listing price of TruAlt Bioenergy IPO IPO?
Based on today's GMP, TruAlt Bioenergy IPO IPO estimated listing price is ₹586 per share (issue price ₹496 + GMP ₹90). The actual listing price will be set on 3 October 2025 when trading starts.
What is the expected profit per lot in TruAlt Bioenergy IPO IPO?
At GMP of ₹90 and lot size of 30 shares, estimated grey market profit is ₹2,700 (1 lot × 30 shares × ₹90). This is unofficial and not guaranteed on listing day.
Will TruAlt Bioenergy IPO IPO list at GMP price?
TruAlt Bioenergy IPO IPO may list around ₹586 based on current GMP of ₹90, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 3 October 2025, the opening price depends on market sentiment, final subscription, and index levels.
What is TruAlt Bioenergy IPO IPO issue price and lot size?
TruAlt Bioenergy IPO IPO issue price is ₹496 per share (price band ₹472.0 - ₹496.0). Lot size is 30 shares. Minimum application is 1 lot.
When is TruAlt Bioenergy IPO IPO listing date?
TruAlt Bioenergy IPO IPO listing date is 3 October 2025. The stock is expected to list on NSE and BSE on that day. GMP can change until listing.
What is TruAlt Bioenergy IPO IPO GMP high and low?
TruAlt Bioenergy IPO IPO GMP made a high of ₹109 on 28 Sept 2025 and a low of ₹0 on 21 Sept 2025 in tracked grey market data.
Can TruAlt Bioenergy IPO IPO GMP change after subscription closes?
Yes. TruAlt Bioenergy IPO IPO closed on 29 September 2025. GMP often moves between the close date and listing date (3 October 2025) based on allotment buzz, market mood, and news. Check this page for the latest GMP before listing.
What is TruAlt Bioenergy IPO IPO subscription status?
Live category-wise subscription for TruAlt Bioenergy IPO IPO is on the TruAlt Bioenergy IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check TruAlt Bioenergy IPO IPO allotment status?
Allotment for TruAlt Bioenergy IPO IPO can be checked on the TruAlt Bioenergy IPO Allotment Status page on IPOwiz, on the registrar website, BSE allotment page, or the IPOwiz App using your PAN.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. GMP verified before publish.